Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


Recent & Breaking News (TSX:EDT)

Spectral Announces Clinical Trial Results

MarketWire Canada October 3, 2016

IIROC Trade Resumption - EDT

Canada NewsWire September 20, 2016

Spectral Responds to Recent Trading Activity

MarketWire Canada September 20, 2016

IIROC Trading Halt - EDT

Canada NewsWire September 20, 2016

Spectral Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016

MarketWire Canada September 7, 2016

Spectral Unaware of Any Material Change

MarketWire Canada August 19, 2016

Spectral on Track With Regulatory Pathway for Novel Septic Shock Treatment

MarketWire Canada August 18, 2016

H2O Innovation: Clearlogx(R) Patented Technology Improves Membrane Plant Performance and Reduces OPEX at Brazos Regional Public Utility Agency (Texas)

MarketWire Canada August 18, 2016

Spectral Announces Second Quarter Results

MarketWire Canada August 12, 2016

Spectral Announces Normal Course Issuer Bid

MarketWire Canada July 4, 2016

FDA Accepts Spectral's Expanded Access Protocol for Toraymyxin(TM)

MarketWire Canada June 27, 2016

Spectral Medical Announces Completion of Enrolment for Its Pivotal EUPHRATES Clinical Trial

MarketWire Canada June 20, 2016

Spectral Medical Announces Acceptance of Pre-Clinical PMA Module for Toraymyxin(TM) by FDA

MarketWire Canada June 16, 2016

Spectral Announces Voting Results of Annual Meeting

MarketWire Canada June 1, 2016

Spectral Medical Files Expanded Access Protocol With FDA for Toraymyxin(TM) Septic Shock Treatment

MarketWire Canada May 31, 2016

CORRECTION FROM SOURCE: Spectral Announces Fourth Quarter and Fiscal 2015 Results

Marketwired March 30, 2016

Spectral Announces Fourth Quarter and Fiscal 2015 Results

Marketwired March 30, 2016

Spectral Commends Inclusion of Organ Dysfunction in New Expert Consensus Definitions of Sepsis and Septic Shock

Marketwired March 7, 2016

Spectral Approaches Finish Line for Clinical and Regulatory Program

Marketwired March 1, 2016

Spectral Medical Inc. Closes Over-Allotment

Marketwired February 24, 2016